Vanguard Group Inc Cogent Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,522,951 shares of COGT stock, worth $97.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,522,951
Previous 6,058,338 7.67%
Holding current value
$97.6 Million
Previous $36.3 Million 29.06%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$4.02 - $7.51 $1.87 Million - $3.49 Million
464,613 Added 7.67%
6,522,951 $46.8 Million
Q1 2025

May 09, 2025
SELL
$5.99 - $9.66 $449,501 - $724,905
-75,042 Reduced 1.22%
6,058,338 $36.3 Million
Q4 2024

Feb 11, 2025
BUY
$7.64 - $12.28 $3.2 Million - $5.15 Million
418,975 Added 7.33%
6,133,380 $47.8 Million
Q3 2024

Nov 13, 2024
BUY
$8.24 - $11.48 $3.75 Million - $5.22 Million
454,526 Added 8.64%
5,714,405 $61.7 Million
Q2 2024

Aug 13, 2024
SELL
$6.01 - $9.04 $3.04 Million - $4.57 Million
-505,826 Reduced 8.77%
5,259,879 $44.3 Million
Q1 2024

May 10, 2024
BUY
$4.38 - $9.02 $5.39 Million - $11.1 Million
1,231,050 Added 27.15%
5,765,705 $38.7 Million
Q4 2023

Feb 14, 2024
BUY
$4.06 - $10.08 $655,056 - $1.63 Million
161,344 Added 3.69%
4,534,655 $26.7 Million
Q3 2023

Nov 14, 2023
SELL
$9.69 - $13.34 $613,473 - $844,555
-63,310 Reduced 1.43%
4,373,311 $42.6 Million
Q2 2023

Aug 14, 2023
BUY
$9.85 - $13.24 $8.87 Million - $11.9 Million
900,362 Added 25.46%
4,436,621 $52.5 Million
Q1 2023

May 15, 2023
BUY
$10.04 - $15.5 $707,488 - $1.09 Million
70,467 Added 2.03%
3,536,259 $38.2 Million
Q4 2022

Feb 10, 2023
BUY
$10.65 - $14.84 $3 Million - $4.19 Million
282,022 Added 8.86%
3,465,792 $40.1 Million
Q3 2022

Nov 14, 2022
BUY
$9.39 - $16.99 $5.61 Million - $10.2 Million
597,966 Added 23.12%
3,183,770 $47.5 Million
Q2 2022

Aug 12, 2022
BUY
$3.92 - $9.73 $3.7 Million - $9.17 Million
942,835 Added 57.39%
2,585,804 $23.3 Million
Q1 2022

May 13, 2022
SELL
$5.31 - $8.7 $51,846 - $84,946
-9,764 Reduced 0.59%
1,642,969 $12.3 Million
Q4 2021

Feb 14, 2022
BUY
$7.51 - $10.81 $417,683 - $601,219
55,617 Added 3.48%
1,652,733 $14.2 Million
Q3 2021

Nov 12, 2021
SELL
$5.99 - $9.14 $57,941 - $88,411
-9,673 Reduced 0.6%
1,597,116 $13.4 Million
Q2 2021

Aug 13, 2021
BUY
$7.82 - $9.3 $12.6 Million - $14.9 Million
1,606,789 New
1,606,789 $13 Million

Others Institutions Holding COGT

# of Institutions
203
Shares Held
117M
Call Options Held
2.84M
Put Options Held
828K
View Full List

About Cogent Biosciences, Inc.

COGT Quotes by TradingView
  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $984M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email